Data
Lookout
Dashboard
Browse
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
FREE PLAN
PM
pdmill@gmail.com
Your clinical trial intelligence
Week of Mar 22 – Mar 29, 2026 · Data from ClinicalTrials.gov
Add to Watchlist
Weekly Report →
4 new sponsors entered Breast Cancer this week
TransThera Sciences, Xiamen University, Queen Mary University of London, and Middle East University filed first-ever trials.
View New Entrants →
26
Critical Changes
Recruitment openings, suspensions
21
Notable Changes
Site expansions, amendments
942
New Trials Posted
Across all disease areas
83
New Entrants
First-ever trials in a disease area
Recent changes on your watchlist
All
Critical
Notable
Critical · Recruitment opened
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive Breast Cancer
NCT07287098
·
Eli Lilly and Company
Not Yet Recruiting →
Recruiting
2d ago
Notable · Site expansion
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1800)
NCT07060807
·
Merck Sharp & Dohme LLC
151 sites
→
154 sites
2d ago
Notable · Site expansion
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in Participants With Breast Cancer
NCT06966700
·
Merck Sharp & Dohme LLC
241 sites
→
249 sites
2d ago
Critical · Sponsor changed
A Study to Evaluate KarXT as a Treatment for Psychosis in Alzheimer's Disease
NCT06585787
·
Karuna Therapeutics
Karuna Therapeutics
→
Karuna Therapeutics, Inc., a BMS company
yesterday
View all 47 changes →
New entrants in Breast Cancer
Last 90 days
TransThera Sciences (Nanjing), Inc.
Tipengoitinib + Fulvestrant · Phase 2 · Recruiting
New entrant
Queen Mary University of London
Germline Testing for Early Detection · NA · Recruiting
New entrant
Xiamen University
Shared Decision-Making Decision Aid · NA · Not Yet Recruiting
New entrant
Middle East University
Pain Management in Stage III and IV · NA · Not Yet Recruiting
New entrant
View all entrants for Breast Cancer →
Your watchlist
Manage →
Breast Cancer
Disease
1,689
trials
640
recruiting
4 new entrants · 3 changes
P3: 155
P2: 311
P1: 153
AstraZeneca
Sponsor
446
trials
209
recruiting
No changes this week
P3: 138
P2: 60
P1: 60
Trending disease areas
Pipeline Pulse →
1
Stroke
7 new
2
Diabetes
6 new
3
Hypertension
5 new
4
Obesity
5 new
5
Breast Cancer
4 new
View all 86 disease areas →
Track more with Starter
You're using 2 of 2 free watchlist slots. Upgrade for 10 trackers, daily email digests, and full landscape reports.
Upgrade — $29/mo →